Beltrn Romero LM, Vallejo-Vaz AJ, Muiz Grijalvo O (2021) Cerebrovascular disease and statins
New opportunities in Page 53 and 54: FC02 Transmembrane Transport: Persp Page 55 and 56: FC04 Pharmacoepidemiology, current Page 57 and 58: R&D at a glance engineering protein Page 59 and 60: FC07 Simulation and data modelling Page 61 and 62: FC09 Inflammation and immunopharmac Page 63 and 64: FC01 Clinical Plenary pharmacology Page 65 and 66: FC02 Transmembrane transport: Persp Page 67 and 68: FC04 Pharmacoepidemiology, current Page 69 and 70: FC06 The heart gone wrong: Stabiliz Page 71 and 72: FC08 Development in the treatment o Page 73 and 74: W04 Symposium: Antioxidants as ther Page 75 and 76: W13 Workshop

Visual and statistical assessments using funnel plots and Beggs and Eggers tests were performed regarding the risk of publication bias ( 3 Results 3.1 Study selection A total of 5,387 records were initially identified806 from PubMed, 1,531 from Embase, 1,175 from Web of Science, and 2,213 from Scopusand after removing 2,284 duplicates, 3,003 studies were screened based on title and abstract
Notably, higher drug retention and permeability were observed in the ex vivo cornea
The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture
Planning for Side Effects If you are moving your shot early because of an eventlike a wedding or a big presentationconsider how the medication affects you personally